Italia markets close in 3 hours 49 minutes

SWTX Sep 2024 70.000 call

OPR - OPR Prezzo differito. Valuta in USD.
Aggiungi a watchlist
1,00000,0000 (0,00%)
In data: 09:38AM EDT. Mercato aperto.
Schermo intero
Chiusura precedente1,0000
Aperto1,0000
Denaro0,0000
Domanda0,0000
Prezzo d'esercizio70,00
Scadenza2024-09-20
Min-Max giorno1,0000 - 1,0000
Contratto - Min-MaxN/D
Volume1
Open Interest65
  • GlobeNewswire

    SpringWorks Therapeutics Reports Second Quarter 2023 Financial Results and Recent Business Highlights

    – Presented additional Phase 3 DeFi data at ASCO demonstrating clinically significant reductions in pain and substantial reductions in tumor volume and T2 hyperintensity with nirogacestat treatment – – Completed enrollment of Phase 2 trial evaluating nirogacestat in patients with ovarian granulosa cell tumors – – Highlighted encouraging Phase 1 and 2 clinical data from emerging pipeline programs at AACR and EHA – STAMFORD, Conn., Aug. 02, 2023 (GLOBE NEWSWIRE) -- SpringWorks Therapeutics, Inc. (